Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Arrowhead Research Corporation Stock Forecast NASDAQ:ARWR
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-11 | 127.6% | Chardan Capital | $94.00 $80.00 | Maintains | Buy |
| 2022-05-11 | -0.43% | SVB Leerink | $36.00 $35.00 | Maintains | Market Perform |
| 2022-05-11 | 70.7% | Baird | $71.00 $60.00 | Upgrades | Neutral Outperform |
| 2022-05-11 | 104.84% | Piper Sandler | $89.00 $72.00 | Maintains | Overweight |
| 2022-02-03 | 2.42% | SVB Leerink | $46.00 $36.00 | Maintains | Market Perform |
| 2022-01-28 | 30.87% | SVB Leerink | $45.00 $46.00 | Maintains | Market Perform |
| 2022-01-19 | - | Goldman Sachs | - | Upgrades | Neutral Buy |
| 2021-11-23 | 28.02% | SVB Leerink | $44.00 $45.00 | Maintains | Market Perform |
| 2021-08-10 | 184.5% | HC Wainwright & Co. | $95.00 $100.00 | Maintains | Buy |
| 2021-08-06 | 167.43% | Chardan Capital | $97.00 $94.00 | Maintains | Buy |
| 2021-02-08 | 201.56% | B. Riley Securities | $98.00 $106.00 | Maintains | Buy |
| 2021-02-05 | 181.65% | Piper Sandler | $90.00 $99.00 | Maintains | Overweight |
| 2021-02-05 | 170.27% | HC Wainwright & Co. | $90.00 $95.00 | Maintains | Buy |
| 2021-02-05 | 175.96% | Chardan Capital | $81.00 $97.00 | Maintains | Buy |
| 2020-12-21 | - | Baird | $75.00 - | Downgrades | Outperform Neutral |
| 2020-11-24 | -3.27% | SVB Leerink | $35.00 $34.00 | Maintains | Market Perform |
| 2020-11-19 | 156.05% | Citigroup | $90.00 | Initiates Coverage On | Buy |
| 2020-09-17 | -11.81% | SVB Leerink | $29.00 $31.00 | Maintains | Market Perform |
| 2020-05-13 | 76.39% | RBC Capital | $62.00 | Initiates Coverage On | Outperform |
| 2020-05-08 | 65.01% | Cantor Fitzgerald | $60.00 $58.00 | Reiterates | Overweight |
| 2020-04-15 | 70.7% | Cantor Fitzgerald | $60.00 | Upgrades | Neutral Overweight |
| 2020-03-24 | - | SVB Leerink | - | Upgrades | Underperform Market Perform |
| 2020-03-17 | 28.02% | Goldman Sachs | $45.00 | Initiates Coverage On | Neutral |
| 2020-03-13 | 62.16% | B. Riley Securities | $83.00 $57.00 | Maintains | Buy |
| 2020-02-06 | 56.47% | Cantor Fitzgerald | $50.00 $55.00 | Maintains | Neutral |
| 2020-01-21 | -8.96% | SVB Leerink | $32.00 | Initiates Coverage On | Underperform |
| 2019-12-13 | - | Oppenheimer | - | Initiates Coverage On | Perform |
| 2019-11-25 | 99.15% | Baird | $39.00 $70.00 | Upgrades | Neutral Outperform |
| 2019-11-19 | 42.25% | Cantor Fitzgerald | $24.00 $50.00 | Maintains | Neutral |
| 2019-11-13 | 67.85% | B. Riley Securities | $46.00 $59.00 | Maintains | Buy |
| 2019-10-24 | 10.95% | Baird | $39.00 | Downgrades | Outperform Neutral |
| 2019-10-22 | 28.02% | Chardan Capital | $32.00 $45.00 | Maintains | Buy |
| 2019-10-03 | 10.95% | Baird | $39.00 | Initiates Coverage On | Outperform |
| 2019-08-19 | 30.87% | B. Riley Securities | $32.00 $46.00 | Maintains | Buy |
| 2019-06-28 | - | Cantor Fitzgerald | - | Downgrades | Overweight Neutral |
ARWR Stock Trend
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.
Given the current short-term trend, the stock is expected to fall -17.46% during the next 3 months and, with a 90% probability hold a price between $23.19 and $34.12 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
WARNING: Trend forecast is still in the development phase and should be used with caution. Some cases might produce unexpected results such as negative prices at the end of the trend.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-23 | $27.95 | $34.57 | $41.20 |
| 2022-05-24 | $27.80 | $34.43 | $41.05 |
| 2022-05-25 | $27.66 | $34.28 | $40.91 |
| 2022-05-26 | $27.52 | $34.14 | $40.77 |
| 2022-05-27 | $27.37 | $34.00 | $40.62 |
| 2022-05-31 | $27.23 | $33.85 | $40.48 |
| 2022-06-01 | $27.09 | $33.71 | $40.34 |
| 2022-06-02 | $26.94 | $33.57 | $40.19 |
| 2022-06-03 | $26.80 | $33.42 | $40.05 |
| 2022-06-06 | $26.66 | $33.28 | $39.91 |
| 2022-06-07 | $26.51 | $33.14 | $39.76 |
| 2022-06-08 | $26.37 | $32.99 | $39.62 |
| 2022-06-09 | $26.23 | $32.85 | $39.48 |
| 2022-06-10 | $26.08 | $32.71 | $39.33 |
| 2022-06-13 | $25.94 | $32.56 | $39.19 |
| 2022-06-14 | $25.80 | $32.42 | $39.05 |
| 2022-06-15 | $25.65 | $32.28 | $38.90 |
| 2022-06-16 | $25.51 | $32.13 | $38.76 |
| 2022-06-17 | $25.37 | $31.99 | $38.62 |
| 2022-06-21 | $25.22 | $31.85 | $38.47 |
| 2022-06-22 | $25.08 | $31.70 | $38.33 |
| 2022-06-23 | $24.94 | $31.56 | $38.19 |
| 2022-06-24 | $24.79 | $31.42 | $38.04 |
| 2022-06-27 | $24.65 | $31.27 | $37.90 |
| 2022-06-28 | $24.51 | $31.13 | $37.76 |
| 2022-06-29 | $24.36 | $30.99 | $37.61 |
| 2022-06-30 | $24.22 | $30.84 | $37.47 |
| 2022-07-01 | $24.07 | $30.70 | $37.33 |
| 2022-07-05 | $23.93 | $30.56 | $37.18 |
| 2022-07-06 | $23.79 | $30.41 | $37.04 |
Arrowhead Pharmaceuticals, Inc., a biopharmaceutical company, develops novel drugs to treat intractable diseases in the United States. The company utilizes its proprietary Dynamic Polyconjugate platform to develop targeted drugs based on the RNA interference mechanism that silences disease-causing genes. Its ARC-520, an RNAi-based therapeutic that is in Phase IIb clinical efficacy studies to treat chronic hepatitis B virus infection; and ARC-AAT,... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
